These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2687716)

  • 41. Species differences in the role of excitatory amino acids in experimental parkinsonism.
    Fornai F; Vaglini F; Maggio R; Bonuccelli U; Corsini GU
    Neurosci Biobehav Rev; 1997 Jul; 21(4):401-15. PubMed ID: 9195598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates: a comparison with L-Dopa treatment.
    Benazzouz A; Boraud T; Féger J; Burbaud P; Bioulac B; Gross C
    Mov Disord; 1996 Nov; 11(6):627-32. PubMed ID: 8914087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease.
    Greenamyre JT; Eller RV; Zhang Z; Ovadia A; Kurlan R; Gash DM
    Ann Neurol; 1994 Jun; 35(6):655-61. PubMed ID: 8210221
    [TBL] [Abstract][Full Text] [Related]  

  • 44. De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset.
    Pearce RK; Banerji T; Jenner P; Marsden CD
    Mov Disord; 1998 Mar; 13(2):234-41. PubMed ID: 9539335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey.
    Crossman AR; Mitchell IJ; Sambrook MA
    Neuropharmacology; 1985 Jun; 24(6):587-91. PubMed ID: 3875056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Developing a stable bilateral model of parkinsonism in rhesus monkeys.
    Smith RD; Zhang Z; Kurlan R; McDermott M; Gash DM
    Neuroscience; 1993 Jan; 52(1):7-16. PubMed ID: 8433810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The highly-selective 5-HT(1A) agonist F15599 reduces L-DOPA-induced dyskinesia without compromising anti-parkinsonian benefits in the MPTP-lesioned macaque.
    Huot P; Johnston TH; Fox SH; Newman-Tancredi A; Brotchie JM
    Neuropharmacology; 2015 Oct; 97():306-11. PubMed ID: 26071982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
    Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH
    Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum.
    Herrero MT; Augood SJ; Hirsch EC; Javoy-Agid F; Luquin MR; Agid Y; Obeso JA; Emson PC
    Neuroscience; 1995 Oct; 68(4):1189-98. PubMed ID: 8544992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study.
    Benazzouz A; Boraud T; Dubédat P; Boireau A; Stutzmann JM; Gross C
    Eur J Pharmacol; 1995 Sep; 284(3):299-307. PubMed ID: 8666012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism.
    Bergman H; Wichmann T; Karmon B; DeLong MR
    J Neurophysiol; 1994 Aug; 72(2):507-20. PubMed ID: 7983515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease.
    Johnston TH; Lee J; Gomez-Ramirez J; Fox SH; Brotchie JM
    Exp Neurol; 2005 Feb; 191(2):243-50. PubMed ID: 15649479
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TC-8831, a nicotinic acetylcholine receptor agonist, reduces L-DOPA-induced dyskinesia in the MPTP macaque.
    Johnston TH; Huot P; Fox SH; Koprich JB; Szeliga KT; James JW; Graef JD; Letchworth SR; Jordan KG; Hill MP; Brotchie JM
    Neuropharmacology; 2013 Oct; 73():337-47. PubMed ID: 23770260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A model of Parkinson's disease: effect of L-dopa therapy on movement parameters and electromyographic activity in monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
    Doudet D; Gross C; Lebrun-Grandié P; Bioulac B
    C R Seances Soc Biol Fil; 1985; 179(1):85-97. PubMed ID: 3161601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys.
    Grondin R; Hadj Tahar A; Doan VD; Ladure P; Bédard PJ
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):181-6. PubMed ID: 10685874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The novel adenosine A2a receptor antagonist ST1535 potentiates the effects of a threshold dose of L-DOPA in MPTP treated common marmosets.
    Rose S; Jackson MJ; Smith LA; Stockwell K; Johnson L; Carminati P; Jenner P
    Eur J Pharmacol; 2006 Sep; 546(1-3):82-7. PubMed ID: 16925991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic administration of MK-801 prevents N-methyl-D-aspartate-induced neuronal degeneration in rat brain.
    Foster AC; Gill R; Kemp JA; Woodruff GN
    Neurosci Lett; 1987 May; 76(3):307-11. PubMed ID: 3295603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alteration of pallidal cholinergic activity in MPTP-treated monkeys: effect of dihydro-alpha-ergocryptine (DEK).
    Curti D; Izzo E; Benzi G
    Neurosci Lett; 1994 Feb; 168(1-2):213-6. PubMed ID: 8028778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys.
    Ouattara B; Gasparini F; Morissette M; Grégoire L; Samadi P; Gomez-Mancilla B; Di Paolo T
    J Neurochem; 2010 May; 113(3):715-24. PubMed ID: 20132464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of terguride, a partial D2 agonist, on MPTP-lesioned parkinsonian cynomolgus monkeys.
    Akai T; Yamaguchi M; Mizuta E; Kuno S
    Ann Neurol; 1993 May; 33(5):507-11. PubMed ID: 8098931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.